UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 13.475

Sortiert nach

Real‐world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1143-1155

2014

Volltextzugriff (PDF)

Randomised clinical trial: delayed‐release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing – ASCEND I and II combined analysis

Alimentary pharmacology & therapeutics, 2011-03, Vol.33 (6), p.672-678

2011

Volltextzugriff (PDF)

Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares

Alimentary pharmacology & therapeutics, 2009-02, Vol.29 (3), p.247-257

2009

Volltextzugriff (PDF)

Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (5), p.546-554

2013

Volltextzugriff (PDF)

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.106-114

2017

Volltextzugriff (PDF)

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (6), p.753-762

2018

Volltextzugriff (PDF)

Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (10), p.1423-1424

2018

Volltextzugriff (PDF)

Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (2), p.264-275

2017

Volltextzugriff (PDF)

Smoking and inflammatory bowel disease

European journal of gastroenterology & hepatology, 2000-08, Vol.12 (8), p.855-862

2000

Volltextzugriff (PDF)

CT colonography with three-dimensional problem solving for detection of colonic polyps

American journal of roentgenology (1976), 1998-10, Vol.171 (4), p.989

1998

Volltextzugriff (PDF)

Ethics of a Paired-Kidney-Exchange Program

The New England journal of medicine, 1997-06, Vol.336 (24), p.1752-1755

1997

Volltextzugriff (PDF)

Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison

The Lancet (British edition), 2005-01, Vol.365 (9456), p.305-311

2005

Volltextzugriff (PDF)

ACG Clinical Guideline: Ulcerative Colitis in Adults

The American journal of gastroenterology, 2019-03, Vol.114 (3), p.384-413

2019

Volltextzugriff (PDF)

Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study

Gut, 2011-07, Vol.60 (7), p.937-943

2011

Volltextzugriff (PDF)

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

The American journal of gastroenterology, 2015-09, Vol.110 (9), p.1324-1338

2015

Volltextzugriff (PDF)

P975 Monitoring Inflammatory Bowel Disease (IBD) by intestinal ultrasound decreases time to treatment change and time to remission in comparison to conventional management: Analysis of patients with IBD on multiple IBD therapies

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1767-i1768

2024

Volltextzugriff (PDF)

Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts

NMR in biomedicine, 2009-07, Vol.22 (6), p.593-600

2009

Volltextzugriff (PDF)

P221 Intestinal ultrasound is predictive of disease relapse in asymptomatic Inflammatory Bowel Disease patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i554-i554

2024

Volltextzugriff (PDF)

P787 Use of upadacitinib to treat IBD in post-liver transplant

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1467-i1467

2024

Volltextzugriff (PDF)

P982 Patients in trials of moderate-to-severe CD who are exposed to placebo are more likely to suffer harm than those receiving active treatment: The lack of clinical equipoise in traditional study designs

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1780-i1781

2024

Volltextzugriff (PDF)

P543 Patients in trials of moderate-to-severe UC who are exposed to placebo are more likely to suffer harm than those receiving active treatment: The lack of clinical equipoise in traditional study designs

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1070-i1071

2024

Volltextzugriff (PDF)

P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease- Real-world Data from a Large Tertiary Center

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1575-i1575

2024

Volltextzugriff (PDF)

DOP70 Prevalence and severity of bowel urgency in Crohn’s Disease: Results from the Communicating Needs and Features of IBD Experience (CONFIDE) Survey

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i201-i202

2024

Volltextzugriff (PDF)

P683 Economic impact of achieving mucosal healing on UC-related hospitalisations and work productivity in patients with moderately to severely active UC: A post-hoc analysis of risankizumab Phase 2b/3 trials

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1298-i1299

2024

Volltextzugriff (PDF)

P901 Extended induction response over time in patients with moderately-to-severely active Ulcerative Colitis treated with mirikizumab in the LUCENT-1 and -2 trials

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1651-i1652

2024

Volltextzugriff (PDF)

1 – 25 von 13.475

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.034)
Mit Volltextzugriff
(11.482)

Publikationsform

8 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(7.189)
Life Sciences & Biomedicine
(5.529)
Humans
(4.748)
Male
(2.633)
Female
(2.543)
Biological And Medical Sciences
(2.464)
Medical Sciences
(1.953)
Adult
(1.605)
Middle Aged
(1.555)
Animals
(1.497)
Physical Sciences
(1.268)
Aged
(1.163)
Physics
(842)
Adolescent
(616)
Fundamental And Applied Biological Sciences. Psychology
(591)
Social Sciences
(572)
Oncology
(553)
Technology
(546)
General & Internal Medicine
(545)
Mice
(520)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(6.060)
Free E-Journal (出版社公開部分のみ）
(5.293)
Ingenta
(5.027)
Publisher website
(4.683)
Journals@Ovid Ovid Full Text
(4.308)
Elsevier ScienceDirect Journals Complete
(2.865)
IngentaConnect Journals
(2.218)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.575)
Wiley Online Library
(1.487)
American Physical Society Journals
(1.060)
JSTOR All Journals
(1.060)
PROLA - Physical Review Online Archive
(1.031)
Wiley Online Library Full Collection 2018
(963)
Oxford Journals
(743)
Springer Journals
(726)
Oxford Journals 2020 Medicine
(525)
Ebook Central Perpetual and DDA
(486)
eBooks on EBSCOhost
(485)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(479)
Springer Nature - Connect here FIRST to enable access
(416)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physical Review. D, Particles, Fields, Gravitation, And Cosmology
(538)
Physical Review Letters
(392)
Gastroenterology
(192)
Physical Review. D
(150)
Journal Of Crohn's And Colitis
(137)
The Astrophysical Journal
(123)
Journal Of Clinical Oncology
(122)
Physics Letters. B
(116)
Chest
(112)
The New England Journal Of Medicine
(109)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt